Researchers discovered that X-rays using gold nanoparticles as contrast agents may more accurately detect kidney disease.
Vous n'êtes pas connecté
A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging technology can detect clear-cell renal cell carcinoma, the most common kind of kidney cancer.
Researchers discovered that X-rays using gold nanoparticles as contrast agents may more accurately detect kidney disease.
UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation therapies will present...
TUESDAY, Oct. 1, 2024 -- Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and...
FRIDAY, Sept. 20, 2024 -- For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy,...
MONDAY, Sept. 23, 2024 -- Kidney stone fragments sometimes just need a little push to be flushed out of a person’s system, a new trial...
Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers...
FRIDAY, Sept. 20, 2024 -- Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk...
A comprehensive study spanning 17 years and involving over 730,000 people treated for high blood pressure has provided valuable insights into the...
It became more common for authorities to charge women with crimes related to their pregnancies after the fall of Roe v. Wade in 2022, a new study...
More than a dozen bacterial species among the hundreds that live in people’s mouths have been linked to a collective 50% increased chance of...